[시장보고서]세계의 무지외반증 수술 시장 : 제품별, 환자 유형별, 유형별, 최종 사용자별, 지역별

세계의 무지외반증 수술 시장 : 제품별, 환자 유형별, 유형별, 최종 사용자별, 지역별 - 예측(-2029년)

Bunion Surgery Market by Product (Correction Systems, Implants & Accessories), Patient Type (Adult, Pediatric), Type (Minimally Invasive Surgery, Traditional Surgery), End User (Hospitals, ASCs, Orthopedic Clinics), Region - Global Forecast to 2029

상품코드 : 1643542 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2025년 01월

페이지 정보 : 영문 234 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 6,781,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,111,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 11,166,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 13,701,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

무지외반증 수술 시장 규모는 2024년 4억 5,840만 달러에서 2029년 6억 610만 달러로 성장할 것으로 예상되며, 예측 기간 동안 5.7%의 성장률을 보일 것으로 예상됩니다.

무지외반증 수술 건수 증가는 무지외반증 수술 시장의 성장을 가속하는 요인입니다. 특히 노년층에서 무지외반증 발병률이 지속적으로 증가함에 따라 변형 교정을 위한 수술적 치료에 대한 수요가 증가하고 있습니다. 또한, 효과적인 치료법에 대한 인식이 높아지고 최소 침습 수술을 포함한 첨단 기술의 발달로 인해 무지외반증 수술 환자 수가 증가하고 있습니다.

조사 범위
조사 대상연도	2022-2029년
기준연도	2023년
예측 기간	2024-2029년
검토 단위	금액(100만 달러)
부문	제품별, 환자 유형별, 유형별, 최종사용자별, 지역별
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동/아프리카, GCC 국가

최종 사용자별로 무지외반증 수술 시장은 병원, 외래수술센터(ASC), 정형외과 클리닉으로 분류됩니다. 예측 기간 동안 병원 부문이 가장 높은 CAGR을 나타낼 것으로 예상됩니다. 이 성장률은 첨단 수술 기술의 가용성과 의료 인프라에 대한 지속적인 투자로 인해 높은 성장률을 보일 것으로 예상됩니다. 병원은 계속 확장하고 새로운 첨단 기술을 채택하고 있어 복잡한 무지외반증 수술에 적합한 선택이 되고 있습니다.

"예측 기간 동안 무지외반증 수술 시장의 유형별 성장률은 최소 침습 수술 부문이 가장 높은 성장률을 기록했습니다.

유형별로 무지외반증 수술 시장은 기존 수술과 최소침습 수술로 나뉩니다. 저침습 수술 분야는 주로 특수 수술 기구와 같은 기술 발전으로 인해 무지외반증 수술 시장에서 가장 높은 CAGR로 성장할 것으로 예상됩니다. 이러한 수술은 무지외반증 수술의 정확성과 신뢰성을 향상시켜 보다 효과적이고 쉽게 이용할 수 있도록 돕고 있습니다.

무지외반증 수술 세계 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카, GCC 국가로 분류됩니다. 특히 아시아태평양은 의료 인프라에 대한 투자가 증가함에 따라 무지외반증 수술 시장에서 가장 높은 CAGR을 기록하고 있습니다. 이와 더불어, 빠르게 고령화되는 환자 수는 무지외반증을 포함한 노화 관련 질환에 대한 효과적인 치료법을 강력하게 요구하고 있습니다. 또한, 아시아태평양의 의료관광 활동의 확대는 고급 수술 치료와 고급 의료 서비스를 찾는 환자가 급증하면서 시장에 큰 영향을 미치고 있습니다. 이러한 요인들을 종합하면 아태지역은 무지외반증 수술 시장의 성장 궤도에 올라서고 있습니다.

이 보고서는 전 세계의 무지외반증 수술 시장을 조사했으며, 제품별/환자 유형별/유형별/최종 사용자별/지역별 동향, 시장 진출기업 프로파일 등을 정리한 보고서입니다.

서론
시장 역학
고객의 비즈니스에 영향을 미치는 동향/혼란
가격 분석
밸류체인 분석
공급망 분석
생태계 분석
투자와 자금조달 시나리오
기술 분석
특허 분석
무역 분석
2025-2026년 주요 컨퍼런스 및 이벤트
규제 상황
Porter의 Five Forces 분석
주요 이해관계자와 구입 기준
무지외반증 수술 시장에 대한 AI의 영향

제6장 무지외반증 수술 시장, 제품별

서론
임플란트 및 액세서리
교정 장치

제7장 무지외반증 수술 시장, 환자 유형별

서론
성인 환자
소아 환자

제8장 무지외반증 수술 시장, 유형별

서론
기존 수술
저침습 수술

제9장 무지외반증 수술 시장, 최종사용자별

서론
병원
외래수술센터(ASC)
정형외과 클리닉

제10장 무지외반증 수술 시장, 지역별

서론
북미
- 북미의 거시경제 전망
- 미국
- 캐나다
유럽
- 유럽의 거시경제 전망
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타
아시아태평양
- 아시아태평양의 거시경제 전망
- 중국
- 일본
- 인도
- 기타
라틴아메리카
- 라틴아메리카의 거시경제 전망
- 브라질
- 멕시코
- 기타
중동 및 아프리카
- 의료 기술 진보가 시장 성장을 촉진
- 중동 및 아프리카 거시경제 전망
GCC 국가
- 첨단 의료 인프라에 대한 주목이 증가가 시장 성장을 촉진
- GCC 국가 거시경제 전망

제11장 경쟁 구도

서론
주요 시장 진출기업의 전략/강점
매출 분석, 2021년-2023년
시장 점유율 분석, 2023년
기업 가치 평가와 재무 지표
브랜드/제품 비교
기업 평가 매트릭스 : 주요 시장 진출기업, 2023년
기업 평가 매트릭스 : 스타트업/중소기업, 2023년
경쟁 시나리오

제12장 기업 개요

주요 시장 진출기업
- STRYKER
- ZIMMER BIOMET
- JOHNSON & JOHNSON SERVICES, INC.
- SMITH+NEPHEW
- ENOVIS CORPORATION
- PARAGON 28, INC.
- TREACE MEDICAL CONCEPTS, INC.
- CONMED CORPORATION
- MEDARTIS AG
- DOUBLE MEDICAL TECHNOLOGY INC.
- ARTHREX, INC.
- ACUMED LLC
- MERETE GMBH
- VOOM MEDICAL DEVICES
- BIOPRO, INC
기타 기업
- DIETER MARQUARDT MEDIZINTECHNIK GMBH
- EXTREMITY MEDICAL
- ASTROLABE
- INVAMED
- ORTIMPLANT ORTHOPAEDICS & MEDICAL DEVICES
- AUXEIN
- EXACTECH, INC.
- JEIL MEDICAL CORPORATION
- AYSAM ORTHOPAEDICS & MEDICAL DEVICES
- DEVA TIBBI MALZEMELER

제13장 부록

LSH

영문 목차

영문목차

The bunion surgery market is expected to grow by USD 606.1 million in 2029 from USD 458.4 million in 2024 at a growth rate of 5.7% during the forecast period. Increasing numbers of bunion surgeries are the factor driving the growth of the bunion surgery market. With the continued increase in incidence of bunions, especially amongst the elderly population, the demands for surgical treatments to correct deformity increase. Additionally, increasing awareness of effective treatment alternatives and the availability of advanced techniques, including minimally invasive procedures, has increased the number of patients for bunion surgery.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD Million)
Segments	Product, Patient Type, Type, and End User
Regions covered	North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries

"Hospitals segment is expected to have the fastest growth rate in the bunion surgery market, by end user, during the forecast period."

Based on end user, the bunion surgery market is segmented into hospital, ambulatory surgery centers, and orthopedic clinics. The hospital segment is expected to have the highest CAGR during the forecasted period. The growth rate can be attributed to the availability of advance surgical techniques, and ongoing investment in healthcare infrastructure. As hospital continues to expand and adopt new and advance technologies they remain the preferred choice for complex bunion surgery.

"Minimally invasive surgeries segment accounted for the highest growth rate in the bunion surgery market, by type, during the forecast period."

Based on type, the bunion surgery market is bifurcated into traditional surgeries and minimally invasive surgeries. The minimally invasive surgeries segment is expected to grow at the highest CAGR in the market of bunion surgery mainly due to advancement in technological such as specialized surgical tools. These surgeries have enhanced the precision and reliability of bunion surgery, making them more effective and accessible.

"Asia Pacific: The fastest-growing region in bunion surgery market."

The global market for bunion surgery is categorized into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. Notably, the Asia-Pacific region marks the highest CAGR in the bunion surgery market, due to increasing investments into healthcare infrastructure. In addition to this, the number of rapidly aging patients strongly demands effective treatments for diseases related to age including bunion. The growing medical tourism activities in the APAC region also happen to be of great influence for the market, given the rapid increase of patients seeking advanced surgical treatments and high-class healthcare services. These factors, collectively, have put the APAC region on a growth trajectory for bunion surgery markets.

The break-up of the profile of primary participants in the bunion surgery market:

By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
By Designation: C-level - 27%, D-level - 18%, and Others - 55%
By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The key players in the market are Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew (UK), Paragon 28, Inc (US), CONMED Corporation (US), Zimmer Biomet (US), Treace Medical Concepts, Inc (US), Enovis Corporation (US), Medartis AG (Switzerland), Double Medical Technology Inc. (China), Arthrex, Inc. (US), Acumed LLC (US), Merete GmbH (Germany), BioPro, Inc. (US), Dieter Marquardt Medizintechnik GmbH (Germany), Exactech, Inc. (US), JEIL MEDICAL CORPORATION (South Korea), Ortimplant Orthopaedics & Medical Devices (Turkey), Astrolabe (Portugal), Extremity Medical (US), Voom Medical Devices (US), INVAMED (US), Auxein (India), Aysam Orthopaedics & Medical Devices (Turkey), and Deva TIbbi Malzemeler (Turkey).

Research Coverage:

This research report categorizes the bunion surgery market by product (correction systems and implants & accessories), by patient type (adult patients and pediatric patients), by type (traditional surgeries and minimally invasive surgeries), by end user (hospitals, ambulatory surgery centers, and orthopedic clinics), and by region (North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the bunion surgery market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements. New product & service launches, and recent developments associated with the bunion surgery market. Competitive analysis of upcoming startups in the bunion surgery market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall bunion surgery market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Increasing burden of bunion surgery, expanding geriatric population, rising incidence of sports injuries and rheumatoid arthritis, growing demand for minimally invasive surgery, increasing research funding and grants ), opportunities (rising number of hospitals and surgical centers worldwide, growth opportunities in emerging markets), restraints (high cost of surgery), and challenges (availability of non-surgical alternatives) influencing the growth of the bunion surgery market.
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the bunion surgery market.
Market Development: Comprehensive information about lucrative markets - the report analyses the bunion surgery market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bunion surgery market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings of leading players like Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew (UK), Paragon 28, Inc (US), and Zimmer Biomet (US).

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
- 2.2.1 SECONDARY DATA
  - 2.2.1.1 Key data from secondary sources
- 2.2.2 PRIMARY DATA
  - 2.2.2.1 Primary sources
  - 2.2.2.2 Key data from primary sources
  - 2.2.2.3 Key industry insights
  - 2.2.2.4 Breakdown of primary interviews
2.3 MARKET SIZE ESTIMATION
- 2.3.1 BOTTOM-UP APPROACH
  - 2.3.1.1 Approach 1: Company revenue estimation approach
  - 2.3.1.2 Approach 2: Presentations of companies and primary interviews
  - 2.3.1.3 Growth forecast
  - 2.3.1.4 CAGR projections
- 2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ASSESSMENT
2.6 RESEARCH ASSUMPTIONS
- 2.6.1 PARAMETRIC ASSUMPTIONS
- 2.6.2 GROWTH RATE ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 BUNION SURGERY MARKET OVERVIEW
4.2 BUNION SURGERY MARKET, BY PRODUCT, 2024 VS. 2029
4.3 BUNION SURGERY MARKET, BY PATIENT TYPE, 2024 VS. 2029
4.4 BUNION SURGERY MARKET, BY TYPE, 2024 VS. 2029
4.5 BUNION SURGERY MARKET, BY END USER, 2024 VS. 2029
4.6 BUNION SURGERY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Increasing burden of bunion surgeries
  - 5.2.1.2 Expanding geriatric population
  - 5.2.1.3 Rising incidence of sports injuries and rheumatoid arthritis
  - 5.2.1.4 Growing demand for minimally invasive surgeries
  - 5.2.1.5 Increasing research funding and grants
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High cost of surgeries
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Rising number of hospitals and surgical centers worldwide
  - 5.2.3.2 Growth opportunities in emerging markets
- 5.2.4 CHALLENGES
  - 5.2.4.1 Availability of non-surgical alternatives
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND OF BUNION SURGERY PRODUCTS
- 5.4.2 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS, BY REGION
- 5.4.3 INDICATIVE SELLING PRICE OF BUNION SURGERY PRODUCTS, BY KEY PLAYER
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
- 5.9.1 KEY TECHNOLOGIES
  - 5.9.1.1 Implants
- 5.9.2 COMPLEMENTARY TECHNOLOGIES
  - 5.9.2.1 Correction systems
- 5.9.3 ADJACENT TECHNOLOGIES
  - 5.9.3.1 Splints
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
- 5.11.1 IMPORT DATA FOR HS CODE 9021
- 5.11.2 EXPORT DATA FOR HS CODE 9021
5.12 KEY CONFERENCES AND EVENTS, 2025-2026
5.13 REGULATORY LANDSCAPE
- 5.13.1 REGULATORY ANALYSIS
  - 5.13.1.1 North America
    - 5.13.1.1.1 US
    - 5.13.1.1.2 Canada
  - 5.13.1.2 Europe
  - 5.13.1.3 Asia Pacific
    - 5.13.1.3.1 China
    - 5.13.1.3.2 Japan
    - 5.13.1.3.3 India
  - 5.13.1.4 Latin America
    - 5.13.1.4.1 Brazil
    - 5.13.1.4.2 Mexico
  - 5.13.1.5 Middle East & Africa
- 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14 PORTER'S FIVE FORCES ANALYSIS
- 5.14.1 THREAT OF NEW ENTRANTS
- 5.14.2 THREAT OF SUBSTITUTES
- 5.14.3 BARGAINING POWER OF BUYERS
- 5.14.4 BARGAINING POWER OF SUPPLIERS
- 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.15.2 BUYING CRITERIA
5.16 IMPACT OF AI ON BUNION SURGERY MARKET
- 5.16.1 INTRODUCTION
- 5.16.2 MARKET POTENTIAL OF AI
- 5.16.3 AI USE CASES
- 5.16.4 FUTURE OF AI/GEN AI

6 BUNION SURGERY MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 IMPLANTS & ACCESSORIES
- 6.2.1 SHIFTING DEMOGRAPHIC PATTERN TO FACILITATE GROWTH
6.3 CORRECTION SYSTEMS
- 6.3.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO DRIVE MARKET

7 BUNION SURGERY MARKET, BY PATIENT TYPE

7.1 INTRODUCTION
7.2 ADULT PATIENTS
- 7.2.1 CHANGING LIFESTYLE PREFERENCES TO PROMOTE GROWTH
7.3 PEDIATRIC PATIENTS
- 7.3.1 INCREASING PREVALENCE OF FLAT FEET AND CEREBRAL PALSY TO AID GROWTH

8 BUNION SURGERY MARKET, BY TYPE

8.1 INTRODUCTION
8.2 TRADITIONAL SURGERIES
- 8.2.1 RISING POOL OF ARTHRITIS PATIENTS TO EXPEDITE GROWTH
8.3 MINIMALLY INVASIVE SURGERIES
- 8.3.1 GROWING ADVANCEMENTS IN SPECIALIZED SURGICAL TOOLS TO FUEL MARKET

9 BUNION SURGERY MARKET, BY END USER

9.1 INTRODUCTION
9.2 HOSPITALS
- 9.2.1 INCREASING DEMAND FOR SPECIALIZED TREATMENTS TO SUSTAIN GROWTH
9.3 AMBULATORY SURGERY CENTERS
- 9.3.1 RISING INCLINATION TOWARD LOWER COSTS AND SHORTER PATIENT STAYS TO STIMULATE GROWTH
9.4 ORTHOPEDIC CLINICS
- 9.4.1 GROWING PREFERENCE FOR EFFECTIVE POST-OPERATIVE CARE AND LIMITED HOSPITALIZATION TO BOOST MARKET

10 BUNION SURGERY MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
  - 10.2.2.1 Increasing number of FDA approvals to facilitate growth
- 10.2.3 CANADA
  - 10.2.3.1 Growing incidence of arthritis to promote growth
10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
  - 10.3.2.1 Increasing incidence of osteoporosis to expedite growth
- 10.3.3 UK
  - 10.3.3.1 Growing demand for surgical treatments to drive market
- 10.3.4 FRANCE
  - 10.3.4.1 Presence of robust healthcare system to augment growth
- 10.3.5 ITALY
  - 10.3.5.1 Growing geriatric population to fuel market
- 10.3.6 SPAIN
  - 10.3.6.1 Rising prevalence of hallux valgus to encourage growth
- 10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
  - 10.4.2.1 Growing public access to modern healthcare to fuel market growth
- 10.4.3 JAPAN
  - 10.4.3.1 Rise in elderly population to support growth
- 10.4.4 INDIA
  - 10.4.4.1 High prevalence of arthritis and foot deformities to encourage growth
- 10.4.5 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
  - 10.5.2.1 Growing cultural focus on appearance to propel market
- 10.5.3 MEXICO
  - 10.5.3.1 Increased availability of advanced surgical techniques to augment growth
- 10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
- 10.6.1 GROWING ADVANCEMENTS IN MEDICAL TECHNOLOGIES TO PROPEL MARKET
- 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.7 GCC COUNTRIES
- 10.7.1 RISING FOCUS ON ADVANCED HEALTH INFRASTRUCTURE TO DRIVE MARKET
- 10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BUNION SURGERY MARKET
11.3 REVENUE ANALYSIS, 2021-2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY VALUATION AND FINANCIAL METRICS
11.6 BRAND/PRODUCT COMPARISON
- 11.6.1 SMITH+NEPHEW
- 11.6.2 ZIMMER BIOMET
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 11.7.1 STARS
- 11.7.2 EMERGING LEADERS
- 11.7.3 PERVASIVE PLAYERS
- 11.7.4 PARTICIPANTS
- 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 11.7.5.1 Company footprint
  - 11.7.5.2 Region footprint
  - 11.7.5.3 Product footprint
  - 11.7.5.4 Patient type footprint
  - 11.7.5.5 Type footprint
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 11.8.1 PROGRESSIVE COMPANIES
- 11.8.2 RESPONSIVE COMPANIES
- 11.8.3 DYNAMIC COMPANIES
- 11.8.4 STARTING BLOCKS
- 11.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2023
  - 11.8.5.1 Detailed list of key startups/SMEs
  - 11.8.5.2 Competitive benchmarking of startups/SMEs
11.9 COMPETITIVE SCENARIO
- 11.9.1 PRODUCT LAUNCHES
- 11.9.2 DEALS

12 COMPANY PROFILES

12.1 KEY PLAYERS
- 12.1.1 STRYKER
  - 12.1.1.1 Business overview
  - 12.1.1.2 Products offered
  - 12.1.1.3 Recent developments
    - 12.1.1.3.1 Product launches
    - 12.1.1.3.2 Deals
    - 12.1.1.3.3 Expansions
    - 12.1.1.3.4 Other developments
  - 12.1.1.4 MnM view
    - 12.1.1.4.1 Right to win
    - 12.1.1.4.2 Strategic choices
    - 12.1.1.4.3 Weaknesses and competitive threats
- 12.1.2 ZIMMER BIOMET
  - 12.1.2.1 Business overview
  - 12.1.2.2 Products offered
    - 12.1.2.2.1 Deals
  - 12.1.2.3 MnM view
    - 12.1.2.3.1 Right to win
    - 12.1.2.3.2 Strategic choices
    - 12.1.2.3.3 Weaknesses and competitive threats
- 12.1.3 JOHNSON & JOHNSON SERVICES, INC.
  - 12.1.3.1 Business overview
  - 12.1.3.2 Products offered
  - 12.1.3.3 Recent developments
    - 12.1.3.3.1 Product launches
    - 12.1.3.3.2 Deals
  - 12.1.3.4 MnM view
    - 12.1.3.4.1 Right to win
    - 12.1.3.4.2 Strategic choices
    - 12.1.3.4.3 Weaknesses and competitive threats
- 12.1.4 SMITH+NEPHEW
  - 12.1.4.1 Business overview
  - 12.1.4.2 Products offered
  - 12.1.4.3 Recent developments
    - 12.1.4.3.1 Deals
  - 12.1.4.4 MnM view
    - 12.1.4.4.1 Right to win
    - 12.1.4.4.2 Strategic choices
    - 12.1.4.4.3 Weaknesses and competitive threats
- 12.1.5 ENOVIS CORPORATION
  - 12.1.5.1 Business overview
  - 12.1.5.2 Products offered
  - 12.1.5.3 Recent developments
    - 12.1.5.3.1 Deals
    - 12.1.5.3.2 Expansions
- 12.1.6 PARAGON 28, INC.
  - 12.1.6.1 Business overview
  - 12.1.6.2 Products offered
  - 12.1.6.3 Recent developments
    - 12.1.6.3.1 Product launches
    - 12.1.6.3.2 Deals
  - 12.1.6.4 MnM view
    - 12.1.6.4.1 Right to win
    - 12.1.6.4.2 Strategic choices
    - 12.1.6.4.3 Weaknesses and competitive threats
- 12.1.7 TREACE MEDICAL CONCEPTS, INC.
  - 12.1.7.1 Business overview
  - 12.1.7.2 Products offered
  - 12.1.7.3 Recent developments
    - 12.1.7.3.1 Product launches
    - 12.1.7.3.2 Deals
    - 12.1.7.3.3 Other developments
- 12.1.8 CONMED CORPORATION
  - 12.1.8.1 Business overview
  - 12.1.8.2 Products offered
- 12.1.9 MEDARTIS AG
  - 12.1.9.1 Business overview
  - 12.1.9.2 Products offered
  - 12.1.9.3 Recent developments
    - 12.1.9.3.1 Product launches
    - 12.1.9.3.2 Deals
- 12.1.10 DOUBLE MEDICAL TECHNOLOGY INC.
  - 12.1.10.1 Business overview
  - 12.1.10.2 Products offered
- 12.1.11 ARTHREX, INC.
  - 12.1.11.1 Business overview
  - 12.1.11.2 Products offered
  - 12.1.11.3 Recent developments
    - 12.1.11.3.1 Product launches
- 12.1.12 ACUMED LLC
  - 12.1.12.1 Business overview
  - 12.1.12.2 Products offered
  - 12.1.12.3 Recent developments
    - 12.1.12.3.1 Expansions
- 12.1.13 MERETE GMBH
  - 12.1.13.1 Business overview
  - 12.1.13.2 Products offered
- 12.1.14 VOOM MEDICAL DEVICES
  - 12.1.14.1 Business overview
  - 12.1.14.2 Products offered
- 12.1.15 BIOPRO, INC
  - 12.1.15.1 Business overview
  - 12.1.15.2 Products offered
12.2 OTHER PLAYERS
- 12.2.1 DIETER MARQUARDT MEDIZINTECHNIK GMBH
- 12.2.2 EXTREMITY MEDICAL
- 12.2.3 ASTROLABE
- 12.2.4 INVAMED
- 12.2.5 ORTIMPLANT ORTHOPAEDICS & MEDICAL DEVICES
- 12.2.6 AUXEIN
- 12.2.7 EXACTECH, INC.
- 12.2.8 JEIL MEDICAL CORPORATION
- 12.2.9 AYSAM ORTHOPAEDICS & MEDICAL DEVICES
- 12.2.10 DEVA TIBBI MALZEMELER

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS